NCT04936529 2026-03-13
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Clinical Trials
18 trialsNCT06057948 2026-03-06
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06741072 2026-01-08
BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
Ohio State University Comprehensive Cancer Center
Phase 1 Suspended
NCT05638698 2024-09-23
TESLA
University of Kansas Medical Center
Phase 2 Active not recruiting
NCT00579423 2023-10-05
Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00470574 2020-11-18
Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00001572 2017-07-02
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00030823 2015-12-30
Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00003224 2014-11-20
Vaccine Therapy in Treating Patients With Metastatic Melanoma
University of Virginia
Phase 1 Completed
NCT00006387 2013-07-11
Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer
Fox Chase Cancer Center
Phase 1 Completed
NCT00003362 2013-06-25
Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00004052 2013-06-25
Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00004249 2013-06-19
Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00006041 2013-06-19
Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00036933 2013-03-25
Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00003819 2013-03-19
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00004929 2013-01-31
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00003357 2012-12-13
Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease
Memorial Sloan Kettering Cancer Center
Phase 1 Completed